One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

Danone has launched a drinkable yogurt product under its Oikos brand in the US which looks to target users of Ozempic and ...

In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 ...

People who took the daily pill orforglipron lost 12 percent of body weight on average after 72 weeks, according to clinical trial results from Lilly.

Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

Danone is launching Oikos Fusion, a dairy-based drink targeting U.S. consumers using weight loss medications like Wegovy.

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...

Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...

In June 2025, Fractyl presented preclinical data at the American Diabetes Association’s 85th Scientific Sessions that showed ...